Navigation Links
New international Ph.D. program on 'Dynamics of Gene Regulation, Epigenetics and DNA Damage Response'
Date:12/21/2011

The Institute of Molecular Biology (IMB) can establish a new International PhD Program in the Life Sciences with the support of the Boehringer Ingelheim Foundation. The program will allow innovative research at the highest international level. In addition to the education of talented young scientists, this initiative improves the integration of institutions in Mainz that conduct research within the field of molecular biology. "The new initiative will help to create synergies between the participating groups. The program will also increase the visibility and international attractiveness of life science research here in Mainz," says Professor Dr. Georg Krausch, President of Johannes Gutenberg University Mainz.

One of the program's key features is the education of doctoral students. "We not only want to attract the best international talents to Mainz, but we also want to offer them opportunities that most institutions cannot offer," states Professor Dr. Christof Niehrs, Founding Director of IMB. Moreover, "we offer our young scientists opportunities to address cutting-edge scientific questions and to work with first-class resources while receiving advanced training." The training program comprises a broad range of lectures and practical courses and is tailored to the specific needs of PhD students. Besides training in up-to-date methods and knowledge, students will be trained in soft-skills such as project management, communication skills, and grant writing to prepare them for a successful career after having finished their doctoral thesis.

The organizers of the program hope this concept will lead to exciting research results and, when combined with very high educational standards, will create the next generation of leading scientists. "This program will set new standards in modern molecular research. Our most sincere thanks go to the Boehringer Ingelheim Foundation. Their further commitment to IMB allows us to attract young and talented scientists to Mainz and also guarantees that our students receive the best possible education," says Gtz Scholz, Chancellor of Johannes Gutenberg University Mainz and Managing Director of IMB.

Research within the program focuses on three cutting-edge areas: Dynamics of Gene Regulation, Epigenetics, and DNA Damage Response. These emerging fields of modern biomedical research are of great significance for basic biological processes and are also linked to diseases such as cancer. For example, the dynamics of gene regulation and epigenetics play an essential role during embryonic development, the adaption of organisms to its environment as well as during ageing, and are of high importance in many diseases. Moreover, the program offers research projects on stem cell biology, which forms the basis for regenerative medicine. The third research focus centers on DNA Damage Response. DNA repair is a key mechanism that protects cells from damage and keeps us healthy. Defects in the DNA repair machinery cause a number of diseases, including cancer.


'/>"/>
Contact: Dr. Ralf Dahm
press@imb-mainz.de
49-613-139-21450
Johannes Gutenberg Universitaet Mainz
Source:Eurekalert

Related biology news :

1. BIO-key(R) International To Exhibit at Oracle OpenWorld
2. Sentara begins international trial -- open at only 24 US locations
3. Perinatal Days and International Stillbirth Conference -- Nov.5-7
4. AVS 55th International Symposium & Exhibition, Oct. 19-24
5. Minnesota ecology professor wins international award for biodiversity and biofuels research
6. International Council for Science launches major research program on natural disasters
7. Innovations in Pediatric Medicine International Conference brings together pediatrics experts
8. International Journal of Social Robotics debuts at Springer
9. Conservation International gets support from Dreamworks Animation to protect giant pandas
10. AACR to host Seventh Annual International Conference on Frontiers in Cancer Prevention Research
11. Engineer to present leak-proof method for carbon dioxide storage at international conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology: